BioCentury
ARTICLE | Financial News

Aradigm financial update

August 9, 2010 7:00 AM UTC

Aradigm plans to exchange about $9.1 million in an outstanding 5% promissory note issued to Novo Nordisk A/S (CSE:NVO; NYSE:NVO, Bagsvaerd, Denmark) for 26 million shares at $0.35. The closing of the...